Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.
Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.
Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.
Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
Therefore, have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Prostate cancer screening program beneficial in top decile of polygenic risk score
2.
Kidney cancer: Understanding what a renal cell carcinoma diagnosis means
3.
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
4.
Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.
5.
For treatment, the majority of cancer patients choose complementary therapies.
1.
Decoding Efficacy, Safety, and Future Frontiers in CAR-T Cell Therapy for Hematologic Malignancies Towards CAR-T Therapy 2025
2.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
3.
Discovering the Benefits of TNK: A Comprehensive Blog Article
4.
Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights
5.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part III
2.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
3.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation